KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Non-Current Assets: 2009-2024

Historic Non-Current Assets for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $20.7 billion.

  • Bausch Health Companies' Non-Current Assets fell 2.90% to $20.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 billion, marking a year-over-year decrease of 2.90%. This contributed to the annual value of $20.7 billion for FY2024, which is 4.62% down from last year.
  • Per Bausch Health Companies' latest filing, its Non-Current Assets stood at $20.7 billion for FY2024, which was down 4.62% from $21.8 billion recorded in FY2023.
  • In the past 5 years, Bausch Health Companies' Non-Current Assets ranged from a high of $25.9 billion in FY2020 and a low of $20.7 billion during FY2024.
  • For the 3-year period, Bausch Health Companies' Non-Current Assets averaged around $21.3 billion, with its median value being $21.4 billion (2022).
  • In the last 5 years, Bausch Health Companies' Non-Current Assets fell by 9.14% in 2022 and then rose by 1.47% in 2023.
  • Bausch Health Companies' Non-Current Assets (Yearly) stood at $25.9 billion in 2020, then decreased by 8.75% to $23.6 billion in 2021, then dropped by 9.14% to $21.4 billion in 2022, then climbed by 1.47% to $21.8 billion in 2023, then declined by 4.62% to $20.7 billion in 2024.